A no-brainer for ending AIDS: The case for a harm reduction decade

Journal of the International AIDS Society

Volumn 19, Issue 1, 2016, Pages

  Cook, Catherine ^a   Lines, Rick ^a   Wilson, David P ^a,b  

^a HARM REDUCTION INTERNATIONAL   (United Kingdom)

^b BURNET INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; COST EFFECTIVENESS ANALYSIS; DRUG CONTROL; DRUG LEGISLATION; DRUG USE; EPIDEMIC; FINANCIAL MANAGEMENT; GOVERNMENT; HARM REDUCTION; HEALTH CARE ACCESS; HEALTH PROGRAM; HUMAN; HUMAN DIGNITY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN RIGHTS; HUMAN RIGHTS ABUSE; INVESTMENT; MEDICAL SOCIETY; MENTAL HEALTH; POLICY; PRIORITY JOURNAL; PUBLIC HEALTH; PUNISHMENT; SHORT SURVEY; WORLD HEALTH ORGANIZATION;

EID: 84974633371     PISSN: None     EISSN: 17582652     Source Type: Journal    
DOI: 10.7448/IAS.19.1.21129     Document Type: Short Survey

References (18)

1. Sustainable Development Goals [Internet]. [cited 2016 Mar 7]. Available from: https://sustainabledevelopment.un.org/?menu1300
2. Csete J, Kamarulzaman A, Kazatchkine M, Altice F, Balicki M, Buxton J, et al. Public health and international drug policy. Lancet. 2016. doi: http://dx.doi. org/10.1016/S0140-6736(16)00619-X
3. Cook C, Phelan M, Sander G, Stone K, Murphy F. The case for a harm reduction decade: progress, potential and paradigm shifts. London: Harm Reduction International; 2016.
4. Wilson DP, Donald B, Shattock AJ, Wilson D, Fraser-Hurt N. The costeffectiveness of harm reduction. Int J Drug Policy. 2015;26:S511.
5. Dutta A, Wirtz A, Stanciole A, Oelrichs R, Semini I, Baral S, et al. The global HIV epidemics among people who inject drugs. Washington, DC: World Bank; 2012.
6. WHO, UNODC, UNAIDS. Technical Guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users. Geneva, Switzerland: World Health Organization; 2012.
7. Joint EMCDDA and ECDC rapid risk assessment: HIV in injecting drug users in the EU/EEA, following a reported increase of cases in Greece and Romania [Internet]. 2012 [cited 2016 Apr 4]. Available from: http://www.emcdda. europa.eu/system/files/publications/666/emcdda-ecdc-2012-riskassessment- 321005.pdf
8. Emmanuel F, Archibald C, Razaque A, Sandstrom P. Factors associated with an explosive HIV epidemic among injecting drug users in Sargodha, Pakistan. J Acquir Immune Defic Syndr. 2009;51(1):8590.
9. Sarkar S, Das N, Panda S, Naik TN, Sarkar K, Singh BC, et al. Rapid spread of HIV among injecting drug users in north-eastern states of India. Bull Narc. 1993;45(1):91105.
10. Choopanya K, Vanichseni S, Des Jarlais DC, Plangsringarm K, Sonchai W, Carballo M, et al. Risk factors and HIV seropositivity among injecting drug users in Bangkok. AIDS. 1991;5(12):150913.
11. Kamarulzaman A, McBrayer JL. Compulsory drug detention centers in East and Southeast Asia. Int J Drug Policy. 2015;26(Suppl 1):S337.
12. Amon JJ, Pearshouse R, Cohen JE, Schleifer R. Compulsory drug detention in East and Southeast Asia: evolving government, UN and donor responses. Int J Drug Policy. 2014;25(1):1320.
13. Joint statement: compulsory drug detention and rehabilitation centres [Internet]. New York: International Labour Organization; 2012. [cited 2016 Apr 4] Available from: http://www.unaids.org/en/media/unaids/contentassets/ documents/document/2012/JC2310-Joint Statement6March12FINAL-en.pdf
14. LSE Expert Group on the Economics of Drug Policy. After the drug wars. London: London School of Economics; 2016.
15. Transform Drug Policy Foundation. Count the costs. 50 years of the war on drugs. 2011. [cited 2016 Apr 16]. Available from: http://www.countthecosts.org/
16. Harm Reduction International, International Drug Policy Consortium & International HIV/AIDS Alliance. The funding crisis for harm reduction: donor retreat, government neglect and the way forward. London: Harm Reduction International; 2014.
17. Harm Reduction Decade [Internet]. [cited 2016 Mar 18]. Available from: http://www.harmreductiondecade.org/
18. Kerr CC, Stuart RM, Gray RT, Shattock AJ, Fraser-Hurt N, Benedikt C, et al. Optima: a model for HIV epidemic analysis, program prioritization, and resource optimization. J Acquir Immune Defic Syndr. 2015;69(3):36576.